IP Library › Granted Patent US 9,512,405
Granted Patent B2
US 9,512,405 · App. 13/713,784 · Granted Dec 6, 2016

Non-enzymatic method for isolating human adipose-derived stromal stem cells

Inventors: Jeffrey M. Gimble (New Orleans, LA); Forum S. Shah (Baton Rouge, LA); Xiying Wu (New Orleans, LA)
Assignee: Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
C12N5/0667A61K35/35
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,512,405
App. No.
13/713,784
Granted
Dec 6, 2016
Kind
B2
Abstract

A simple method was developed to extract adipose-derived stromal stem cells (ASCs) without using enzymatic digestion of the collagen in adipose tissue. The resulting ASCs isolated by the simple wash method have lower levels of CD34 expression, a hematopoietic stem cell marker, as compared to ASCs isolated using conventional enzymatic digestion using collagenase. This characteristic is consistent with non-enzymatically treated stem cells obtained from bone marrow aspirates, which are negative for CD34. Additionally, the washed ASCs have higher levels of CD44 expression, a hyaluronate receptor, and lower levels of contaminating hematopoietic cells, as evidenced by low CD45 expression, as compared to enzymatically digested cells. The cells produced by this simple method can be used therapeutically for allogenic or autologous tissue regeneration, and can be administered using any pharmaceutically acceptable carrier. In addition, the cells can be administered in a matrix, lattice, scaffold, or other biologically compatible materials.

Claims (15)

1. A method to concentrate adipose-derived stromal stem cells from adipose tissue from a mammalian donor; said method comprising the following steps:

(a) collecting a lipoaspirate of adipose tissue from the donor;

(b) separating the lipoaspirate in aqueous buffer into a floating adipose layer and a lower aqueous aspirate fluid;

(c) isolating the floating adipose layer; (d) mixing the isolated adipose layer from step (c) with buffer at a temperature between about 25° C. and about 45° C.;

(e) shaking the mixture from step (d) for a time less than about 5 minutes, and then allowing the mixture to settle into an upper supernatant and a lower infranatant;

(f) separating the supernatant from step (e) from the infranatant from step (e);

(g) repeating steps (d) through (f), using in step (d) adipose cells from the separated supernatant from step (f) to mix with the buffer instead of the floating adipose layer from step (c);

(h) combining the infranatants from all repetitions; and

(i) centrifuging the combined infranatants into a cell pellet and a aqueous supernatant, whereby the cell pellet comprises concentrated adipose-derived stromal stem cells;

wherein the concentrated adipose-derived stromal stem cells have not been subjected to enzymatic digestion or antibody affinity purification.

2. The method of claim 1 , wherein the mammalian donor is a human.

3. The method of claim 1 , additionally comprising the step of resuspending the cell pellet in a medium.

4. The method of claim 3 , additionally comprising the step of culturing cells from the medium suspension.

5. The method of claim 3 , wherein the medium comprises stromal medium.

6. The method of claim 5 , additionally comprising the step of culturing cells from the stromal medium suspension.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2013
From: GIMBLE, JEFFREY M.; SHAH, FORUM S.; WU, XIYING
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 029979/0961 →
Continuity (2)
Provisional Application 61570495 · Dec 14, 2011
Related Publication 20140017783A1 · Jan 16, 2014